Protein aggregation-Pathways and influencing factors

被引:638
作者
Wang, Wei [1 ]
Nema, Sandeep [1 ]
Teagarden, Dirk [1 ]
机构
[1] Pfizer Inc, Global Biol, Chesterfield, MO 63017 USA
关键词
Aggregation; Oligomerization; Melting; Formulation; Excipient; Stabilization; INTERLEUKIN-1 RECEPTOR ANTAGONIST; MONOCLONAL-ANTIBODY; BETA-LACTOGLOBULIN; HIGH-PRESSURE; THERMAL AGGREGATION; PHYSICAL STABILITY; ALPHA-SYNUCLEIN; FED-BATCH; HEAT; KINETICS;
D O I
10.1016/j.ijpharm.2010.02.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Proteins generally will tend to aggregate under a variety of environmental conditions in comparison with small drug molecules. The extent of aggregation is dependent on many factors that can be broadly classified as intrinsic (primary, secondary, tertiary or quaternary structure) or extrinsic (environment in which protein is present, processing conditions, etc). These protein aggregates may exhibit less desirable characteristics like reduced or no biological activity, potential for immunogenicity or other side effects. Protein aggregation remains one of the major challenges in the development and commercialization of biotechnology products. This article is intended to review and discuss the latest understandings in protein aggregation pathways and the possible extrinsic factors that affect or control the protein aggregation process. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 99
页数:11
相关论文
共 103 条
[1]   The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state [J].
Abdul-Fattah, Ahmad M. ;
Lechuga-Ballesteros, David ;
Kalonia, Devendra S. ;
Pikal, Michael J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (01) :163-184
[2]   Relationship between β4 hydrogen bond and β6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S [J].
Adachi, Kazuhiko ;
Ding, Min ;
Asakura, Toshio ;
Surrey, Saul .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2009, 481 (02) :137-144
[3]   High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics [J].
Alford, John R. ;
Kendrick, Brent S. ;
Carpenter, John F. ;
Randolph, Theodore W. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (08) :3005-3021
[4]   Measurement of the second osmotic virial coefficient for protein solutions exhibiting monomer-dimer equilibrium [J].
Alford, John R. ;
Kendrick, Brent S. ;
Carpenter, John F. ;
Randolph, Theodore W. .
ANALYTICAL BIOCHEMISTRY, 2008, 377 (02) :128-133
[5]   Nucleation, growth, and activation energies for seeded and unseeded aggregation of α-chymotrypsinogen A [J].
Andrews, Jennifer M. ;
Weiss, William F. ;
Roberts, Christopher J. .
BIOCHEMISTRY, 2008, 47 (08) :2397-2403
[6]   L-Tyrosine prevents aggregation of therapeutic proteins by γ-irradiation [J].
Assemand, E ;
Lacroix, M ;
Mateescu, MA .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2003, 38 :151-156
[7]   Prevention of human granulocyte colony-stimulating factor protein aggregation in recombinant Pichia pastoris fed-batch fermentation using additives [J].
Bahrami, Ali ;
Shojaosadati, Seyed Abbas ;
Khalilzadeh, Rasoul ;
Mohammadian, Jafar ;
Farahani, Ebrahim Vashghani ;
Masoumian, Mohammad Reza .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2009, 52 :141-148
[8]   Role of arginine in the stabilization of proteins against aggregation [J].
Baynes, BM ;
Wang, DIC ;
Trout, BL .
BIOCHEMISTRY, 2005, 44 (12) :4919-4925
[9]   Precipitation of a Monoclonal Antibody by Soluble Tungsten [J].
Bee, Jared S. ;
Nelson, Stephanie A. ;
Freund, Erwin ;
Carpenter, John F. ;
Randolph, Theodore W. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (09) :3290-3301
[10]   Monoclonal Antibody Interactions With Micro- and Nanoparticles: Adsorption, Aggregation, and Accelerated Stress Studies [J].
Bee, Jared S. ;
Chiu, David ;
Sawicki, Suzanne ;
Stevenson, Jennifer L. ;
Chatterjee, Koustuv ;
Freund, Erwin ;
Carpenter, John F. ;
Randolph, Theodore W. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (09) :3218-3238